Neuroregenerative Potential of Intravenous G-CSF and Autologous Peripheral Blood Stem Cells

NCT02983708 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

57

Enrollment

OTHER

Sponsor class

Conditions

Neurodegeneration
G-CSF
Peripheral Blood Mononuclear Cells
Cerebral Palsy

Interventions

BIOLOGICAL: Peripheral blood mononuclear cells (mPBMC)
DRUG: G-CSF
DRUG: Placebo

Sponsor

Hanyang University Seoul Hospital

Collaborators

[object Object]